Top Markets
Coin of the day
PhaseRx, Inc. PhaseRx, Inc.

PhaseRx, Inc.

PZRXQ
Rank in Stocks #42474
PhaseRx, Inc. is a biopharmaceutical company dedicated to developing treatments... PhaseRx, Inc. is a biopharmaceutical company dedicated to developing treatments for inherited enzyme deficiencies affecting the liver. Its therapeutic strategy involves intracellular enzyme replacement, powered by its unique Hybrid mRNA technology platform, which facilitates the production of absent enzymes directly within the body's cells. The company's pipeline includes several programs targeting urea cycle disorders, such as PRX-OTC for ornithine transcarbamylase deficiency, PRX-ASL for argininosuccinate lyase deficiency, and PRX-ASS1 for argininosuccinate synthetase deficiency. Established in 2006, PhaseRx is headquartered in Seattle, Washington.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$1.17K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade PhaseRx, Inc. (PZRXQ)

Category

Stock split history for PhaseRx, Inc. (PZRXQ)
PhaseRx, Inc. stock (symbol: PZRXQ) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 12, 2026.
One PZRXQ share bought prior to Aug 12, 2026 would equal to 0 PZRXQ shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR